Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
November 08, 2025 17:13 ET Â | Source: Intellia Therapeutics, Inc. Deep, stable…
Louis Limited Sets New Standard for Trading Psychology With Dynamic Emotion Tracking Features
Louis Limited sets a new benchmark in trading psychology with a feature-rich…
NEXTGEN DIGITAL CLOSES FIRST TRANCHE OF NON-BROKERED PRIVATE PLACEMENT OF UNITS
– NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE…
Photonic Inc. Advances to Stage B of DARPAs Quantum Benchmarking Initiative
The company’s unique qubit modality and architecture successfully met Stage A requirements,…
Lakeside Software Expands Global Footprint with New SysTrack Cloud Region in Azure India
New region enhances performance, data residency, and scalability for enterprise IT teams…
LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
November 05, 2025 08:00 ET Â | Source: LENZ Therapeutics, Inc. VIZZTM (aceclidine…
Virtune launches Virtune Stablecoin Index ETP on Nasdaq Stockholm, Nasdaq Helsinki and Deutsche Brse Xetra
November 05, 2025 03:49 ET Â | Source: Virtune AB (Publ) Stockholm, November…
Belite Bio Announces UKs Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
November 02, 2025 09:00 ET Â | Source: Belite Bio, Inc MHRA response…
FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
October 31, 2025 16:30 ET Â | Source: FibroBiologics, Inc. Advancing preparations to…
Lucas GC Limited Announces 1H 2025 Financial Results: Revenue at US$54.01 million with Increases in Gross Margin
October 31, 2025 17:00 ET Â | Source: Lucas GC Limited NEW YORK,…